Jack Cuzick, PhD | Authors

Duration of Aromatase Inhibitor Treatment in Breast Cancer: The Role of the ‘Carryover Effect’

December 15, 2013

The so-called “carryover” effect of tamoxifen results in the reduction in recurrence continuing well after treatment has stopped. The carryover effect is seen mostly in the first 5 years after treatment cessation, and recent evidence suggests that after that time, it is largely over.